Advertisement

A New Type of Aspartic Proteinase Inhibitors with a Symmetric Structure

  • N. I. Tarasova
  • S. V. Gulnik
  • A. A. Prishchenko
  • M. V. Livantsov
  • E. N. Lysogorskaya
  • E. S. Oksenoit
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 306)

Abstract

Molecules of aspartic proteinases of mammalian and fungal origin are known to consist of one polypeptide chain forming two structurally similar domains.1–3 The molecules in whole possess pseudosymmetric structure with two-fold axis of symmetry. In contrast to cellular aspartic proteinases, the enzymes of retroviruses can function in the form of homodimers only.4,5 The active site is formed during dimerization so that each subunit contributes one Asp25 residue to the catalytic site. Thus the active molecule is perfectly symmetric. At the same time the substrates of the enzyme are not symmetric as peptide chains are always directed. So in the active site of a retroviral proteinase the productive binding of the substrate is possible both “from east to west” and vise versa, “from west to east”. X-ray analysis studies have revealed that binding of inhibitors and, most likely, substrates causes significant conformational changes in aspartic proteinases.6–8 In the case of HIV proteinase such changes were shown to disturb the symmetry of the molecule.9,10 But this may not be necessary in the case of binding of a symmetric inhibitor, and symmetric structures may have a significant advantage both in affinity and in selectivity, as the degree of symmetry is much higher for the viral enzymes compared to cellular ones.

Keywords

Aspartic Proteinase Anthranilic Acid Peptide Moiety Significant Conformational Change Productive Binding 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J. Tang, M. N. G. James, I.-N. Hsu, J. A. Jenkins and T. L. Blundell, Nature 271: 618–621 (1978).PubMedCrossRefGoogle Scholar
  2. 2.
    N. S. Andreeva, A. A. Fedorov, A. E. Gustchina, R. R. Riskulov, M. G. Sufro and N. E. Shutzkever, Mol. Biol. (Mosk) 12: 704–717 (1978).Google Scholar
  3. 3.
    M. N. G. James and A. R. Sielecki, J. Mol. Biol. 163: 299–361 (1983).PubMedCrossRefGoogle Scholar
  4. 4.
    T. D. Meek, B. D. Dayton, B. W. Metcalf, G. B. Dreyer, J. E. Strickler, J. G. Gorniak, M. Rosenberg, M. L. Moore, V. W. Magaard and C. Debouck, Proc. Natl. Acad. Sci. U.S.A. 86: 1841–1845 (1989).PubMedCrossRefGoogle Scholar
  5. 5.
    M. Miller, M. Jaskólski, J. K. M. Rao, J. Leis and A. Wlodawer, Nature 337: 576–579 (1989).PubMedCrossRefGoogle Scholar
  6. 6.
    K. Suguna, E. A. Padlan, C. W. Smith, W. D. Carlson and D. R. Davies, Proc. Natl. Acad. Sci U.S.A. 84: 7009–7013 (1987).PubMedCrossRefGoogle Scholar
  7. 7.
    S. I. Foundling, J. Cooper, F. E. Watson, A. Cleasy, L. H. Pearl, B. L. Sibanda, A. Hemming, S. P. Wood, T. L. Blundell, M. J. Valler, C. G. Norey, J. Kay, J. Boger, B. M. Dunn, B. J. Leckie, D. M. Jones, B. Atrash, A. Hallett and M. Szelke, Nature 327: 349–352 (1987).PubMedCrossRefGoogle Scholar
  8. 8.
    A. Sali, B. Veerapandian, J. B. Cooper, S. I. Foundling, D. J. Hoover and T. L. Blundell, The EMBO Journal 8: 2179–2188 (1989).PubMedGoogle Scholar
  9. 9.
    M. Miller, J. Schneider, B. K. Sathyanarayna, M. V. Toth, G. R. Marshall, L. Clawson, L. Selk, S. B. H. Kent and A. Wlodaver, Science 246: 1149–1152.Google Scholar
  10. 10.
    A. L. Swain, M. Miller, J. Green, D. H. Rich, S. B. H. Kent and A. Wlodawer, Proc. Natl. Acad. Sci. U.S.A. in press (1990).Google Scholar
  11. 11.
    U.M. Szelke, in: “Aspartic Proteinases and Their Inhibitors,” V. Kostka, ed., 421–441 de Gruyter, Berlin, 1985.Google Scholar
  12. 12.
    I. Ju. Filippova, E. N. Lysogorskaya, E. S. Oksenoit, Ju. E. Komarov and V. M. Stepanov, Bioorg. Chem. (Mosk) 12: 1172–1180 (1986).Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • N. I. Tarasova
    • 1
  • S. V. Gulnik
    • 1
  • A. A. Prishchenko
    • 1
  • M. V. Livantsov
    • 1
  • E. N. Lysogorskaya
    • 1
  • E. S. Oksenoit
    • 1
  1. 1.Department of ChemistryMoscow State UniversityMoscowUSSR

Personalised recommendations